In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

For decades now, Google has been the unquestioned champion of search—our digital oracle, the first and last stop for every question, from “What’s the best pizza place near me?” to “How many protons ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Multiple tests have suggested ChatGPT is using Google Search. Well, a new report seems to confirm ChatGPT is indeed using Google Search data. The details. OpenAI used SerpApi, an 8-year-old scraping ...

I am seeing numerous tests now that seem to prove that OpenAI's ChatGPT search feature is using Google Search's index or search results page to serve its own search results. First, Abhishek Iyer ...

Google Search can now call local businesses using AI to gather pricing and availability info on your behalf. Here's how it works. Google Search can now make AI-powered calls to local businesses.

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...